Abstract
Severe acute respiratory syndrome coronavirus 2 has had an indelible effect, with 153,738,171 cases recorded globally as per the World Health Organization's dashboard. The medical establishment is racing to find repurposed medications that can be successful against this novel coronavirus due to a shortage of new drugs to treat the disease. Favipiravir, an antiviral drug originally developed for influenza, is one of the drugs that has recently received a lot of attention, particularly in India. Here, we present a case of favipiravir-induced drug fever in a young adult coronavirus disease 2019 patient.
References
May 1, 1987·Annals of Internal Medicine·P A Mackowiak, C F LeMaistre
Mar 8, 2003·Archives of Internal Medicine·Ophyr MouradAllan S Detsky
Dec 25, 2009·Pharmacotherapy·Ruchi A Patel, Jason C Gallagher
Jun 9, 2020·BioRxiv : the Preprint Server for Biology·A ShannonB Canard
Jun 17, 2020·The Tohoku Journal of Experimental Medicine·Eikan MishimaTakaaki Abe
Aug 9, 2020·IJC Heart & Vasculature·Hardik D DesaiKamal Sharma
Sep 15, 2020·IJC Heart & Vasculature·Hardik D DesaiPratiksha Moliya
Sep 30, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Hiroyuki TakoiShinji Abe
Nov 3, 2020·Curēus·Ravi SinghaviDhigishaba Jadeja
Jan 19, 2021·SN Comprehensive Clinical Medicine·Kamal SharmaDhruv Gadhiya
Feb 6, 2021·Curēus·Hardik D DesaiNeel N Patel
Mar 16, 2021·Curēus·Hardik D DesaiSaurav Kini
Mar 16, 2021·SN Comprehensive Clinical Medicine·Kamal Sharma, Hardik D Desai
May 22, 2021·Journal of Family Medicine and Primary Care·Ajaz Ahmed Z AnsariHarshil M Desai
May 28, 2021·Journal of Family Medicine and Primary Care·Tanisha VoraHardik D Desai